FDA Approved: AUGMENTIN ES-600 — Supplemental Application (USAntibiotics, LLC)

View source ↗

Summary

FDA approved a supplemental application for AUGMENTIN ES-600 by USAntibiotics, LLC, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Lower Respiratory Tract Infection
• Otitis Media
• Skin Infection
• Urinary Tract Infection

Drugs mentioned

• AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM)

Snippet

SUPPL AP for AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM)